Skip to main content
Top
Literature
1.
go back to reference Cohn CS, Delaney M, Johnson ST, et al. (2020) Technical manual. 20th ed. Bethesda, MD: AABB Cohn CS, Delaney M, Johnson ST, et al. (2020) Technical manual. 20th ed. Bethesda, MD: AABB
3.
go back to reference Bianco T, Farmer BJ, Sage RE, Dobrovic A (2001) Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 97(11):3633–3639CrossRefPubMed Bianco T, Farmer BJ, Sage RE, Dobrovic A (2001) Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 97(11):3633–3639CrossRefPubMed
4.
go back to reference Bianco-Miotto T, Hussey DJ, Day TK, O’Keefe DS, Dobrovic A (2009) DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS ONE 4(3):e4788CrossRefPubMedPubMedCentral Bianco-Miotto T, Hussey DJ, Day TK, O’Keefe DS, Dobrovic A (2009) DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS ONE 4(3):e4788CrossRefPubMedPubMedCentral
5.
go back to reference Prakash S, Mohapatra S, Bhagavathi MS, Das N, Krushna Ray G, Mukherjee S (2021) Loss and reappearance of A antigen after chemotherapy leading to blood group discrepancy in acute myeloid leukemia: a case report. Lab Med 52(5):509–513CrossRefPubMed Prakash S, Mohapatra S, Bhagavathi MS, Das N, Krushna Ray G, Mukherjee S (2021) Loss and reappearance of A antigen after chemotherapy leading to blood group discrepancy in acute myeloid leukemia: a case report. Lab Med 52(5):509–513CrossRefPubMed
Metadata
Title
Weakening of A Antigen in Myelodysplastic Syndrome-Mimicking a Case of Wrong Blood in Tube
Authors
Ayesha Sinha
Najla Haneefa Basheela
Durba Biswas
Debapriya Basu
Suvro Sankha Datta
Publication date
08-12-2023
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2024
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-023-01717-3

Other articles of this Issue 2/2024

Indian Journal of Hematology and Blood Transfusion 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine